May 8 |
Anika Therapeutics appoints Steve Griffin as finance chief
|
May 8 |
Anika Therapeutics Non-GAAP EPS of $0.09 beats by $0.17, revenue of $40.5M beats by $1.36M
|
May 8 |
Anika Announces CFO Transition
|
May 8 |
Anika Reports First Quarter 2024 Financial Results
|
May 7 |
Anika Therapeutics Q1 2024 Earnings Preview
|
May 3 |
Anika Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
|
Apr 25 |
Anika Therapeutics (NASDAQ:ANIK) shareholders have endured a 37% loss from investing in the stock three years ago
|
Apr 18 |
Anika to Issue First Quarter 2024 Financial Results on Wednesday, May 8, 2024
|
Apr 11 |
Is DexCom (DXCM) Outperforming Other Medical Stocks This Year?
|